Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Glatiramer acetate induced hepatotoxicity.
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis Patients
AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis
Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
FOCIS 2013: Improving Human Health Through Immunology
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Dimethyl fumarate protection against collagen II degradation.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Gordon Research Conference on Notch Signaling in Development, Regeneration & Disease
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Pages
« first
‹ previous
…
76
77
78
79
80
81
82
83
84
…
next ›
last »